Lia Gore, University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz Medical Campus

Lia Gore, University of Colorado Cancer Center

Caption

Lia Gore, M.D., and colleagues report positive results in worldwide phase II trial of dasatinib in pediatric CML.

Credit

University of Colorado Cancer Center

Usage Restrictions

With attribution

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.